$1.92
+0.02 (+1.05%)
Open$1.82
Previous Close$1.90
Day High$1.98
Day Low$1.82
52W High$30.12
52W Low$19.11
Volume—
Avg Volume221.9K
Market Cap71.46M
P/E Ratio49.17
EPS$0.46
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,404.7% upside
Current
$1.92
$1.92
Target
$28.89
$28.89
$16.92
$28.89 avg
$30.86
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.01M | 9.02M | 8.76M |
| Net Income | -596,230 | -528,269 | -565,775 |
| Profit Margin | -6.6% | -5.9% | -6.5% |
| EBITDA | -746,119 | -716,524 | -642,558 |
| Free Cash Flow | -600,890 | -503,274 | -433,552 |
| Rev Growth | +12.0% | +12.6% | +22.9% |
| Debt/Equity | 0.77 | 0.69 | 0.70 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |